Artwork

コンテンツは Squirro によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、Squirro またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal
Player FM -ポッドキャストアプリ
Player FMアプリでオフラインにしPlayer FMう!

Dave Latshaw, Ph.D., MBA - Integration of AI in Life Sciences and Biotechnology Sectors

27:27
 
シェア
 

Manage episode 409684261 series 3454356
コンテンツは Squirro によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、Squirro またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal

In this episode, Dave Latshaw, Ph.D., MBA - Integration of AI in Life Sciences and Biotechnology Sectors - Lauren Hawker Zafer is joined by⁠ Dave Latshaw, Ph.D., MBA.

Join host Lauren Hawker Zafer as she engages in a riveting discussion with Dave Latshaw, Ph.D., MBA a visionary leader renowned for his groundbreaking work at Johnson & Johnson and founding Biophysics.

Together, they unravel the complexities of integrating AI into the life sciences and biotechnology sectors, exploring topics ranging from cost-saving implementations to ethical considerations in drug development.

This episode is a must-listen for entrepreneurs, healthcare professionals, and AI enthusiasts eager to understand the transformative potential and ethical implications of AI in shaping the future of healthcare and drug development.

Who is Dave Latshaw, Ph.D., MBA?

Dave received his Ph.D. in chemical and biomolecular engineering from North Carolina State University and went on to get his MBA at Wharton. He began his career at The Janssen Pharmaceutical Companies of Johnson and Johnson, working in a group that was responsible for overseeing the manufacturing of large molecule antibodies, and was the youngest person ever to lead an AI research group at J&J.

Dave also led flagship programs for the company’s AI Advanced Center of Excellence, and enabled J&J’s billion dose commitment during the COVID pandemic. Before leaving J&J and pursuing his MBA, Dave was inducted into Frontiers of Engineering, an organization created by the National Academy of Engineering to recognize top early-career engineers.

While studying at Wharton, the idea of BioPhy originated and later evolved into a life sciences health tech company in 2020. Dave examines opportunities down to first principles using a blend of business acumen, analytics, and the scientific process to use artificial intelligence and biophysics concepts to bring value to the healthcare value chain.

#ai #data #redefiningai #techpodcast #generativeai

  continue reading

105 つのエピソード

Artwork
iconシェア
 
Manage episode 409684261 series 3454356
コンテンツは Squirro によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、Squirro またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal

In this episode, Dave Latshaw, Ph.D., MBA - Integration of AI in Life Sciences and Biotechnology Sectors - Lauren Hawker Zafer is joined by⁠ Dave Latshaw, Ph.D., MBA.

Join host Lauren Hawker Zafer as she engages in a riveting discussion with Dave Latshaw, Ph.D., MBA a visionary leader renowned for his groundbreaking work at Johnson & Johnson and founding Biophysics.

Together, they unravel the complexities of integrating AI into the life sciences and biotechnology sectors, exploring topics ranging from cost-saving implementations to ethical considerations in drug development.

This episode is a must-listen for entrepreneurs, healthcare professionals, and AI enthusiasts eager to understand the transformative potential and ethical implications of AI in shaping the future of healthcare and drug development.

Who is Dave Latshaw, Ph.D., MBA?

Dave received his Ph.D. in chemical and biomolecular engineering from North Carolina State University and went on to get his MBA at Wharton. He began his career at The Janssen Pharmaceutical Companies of Johnson and Johnson, working in a group that was responsible for overseeing the manufacturing of large molecule antibodies, and was the youngest person ever to lead an AI research group at J&J.

Dave also led flagship programs for the company’s AI Advanced Center of Excellence, and enabled J&J’s billion dose commitment during the COVID pandemic. Before leaving J&J and pursuing his MBA, Dave was inducted into Frontiers of Engineering, an organization created by the National Academy of Engineering to recognize top early-career engineers.

While studying at Wharton, the idea of BioPhy originated and later evolved into a life sciences health tech company in 2020. Dave examines opportunities down to first principles using a blend of business acumen, analytics, and the scientific process to use artificial intelligence and biophysics concepts to bring value to the healthcare value chain.

#ai #data #redefiningai #techpodcast #generativeai

  continue reading

105 つのエピソード

Alle episoder

×
 
Loading …

プレーヤーFMへようこそ!

Player FMは今からすぐに楽しめるために高品質のポッドキャストをウェブでスキャンしています。 これは最高のポッドキャストアプリで、Android、iPhone、そしてWebで動作します。 全ての端末で購読を同期するためにサインアップしてください。

 

クイックリファレンスガイド